People in the News

Apr 25, 2018

Jacob Thaysen and Sam Raha

Agilent Technologies has appointed Jacob Thaysen president of the firm's life sciences and applied markets group, replacing Patrick Kaltenbach, who left the company on April 20. Thaysen currently serves as a senior vice president at the company and as president of its diagnostics and genomics group. He joined Agilent in 2012 as part of the acquisition of Dako, where he served as corporate vice president of R&D. Before that, Thaysen was founding partner and chief technology officer of Cantion, a research and defense application development company based in Denmark.

Agilent also announced that Sam Raha, who currently serves as senior vice president of the firm's strategy and corporate development group, will take over as president of the diagnostics and genomics group. Raha previously served as vice president of global marketing at Illumina, and vice president and general manager of the genomic assays business unit at Life Technologies. He also held the position of vice president and general manager of Agilent's Americas field operations for the life sciences and chemical analysis group from 2004 to 2007.

Thaysen's and Raha's appointments are effective immediately, and both will continue to report to Agilent President and CEO Mike McMullen, the firm said.

Apr 24, 2018

Kim Kelderman

Bio-Techne has hired Kim Kelderman as president of Diagnostics and Genomics, effective April 30. Based in California, Kelderman will lead Bio-Techne's diagnostics business, and drive and develop the company's initiatives in genomics and genomics-based diagnostics. He joins Bio-Techne from Thermo Fisher Scientific, where for the past three years he managed the platforms and content of the Genetic Sciences Division. In that position he was responsible for the instrumentation, software, consumables, and assays businesses, and brands including Applied Biosystems and legacy Affymetrix. Prior to being at Thermo Fisher, he was a segment leader at Becton Dickinson. 

Apr 24, 2018

Heiner Dreismann

Heiner Dreismann, former CEO of Roche Molecular Systems, has joined the executive advisory board of MyDx, maker of a multi-use handheld chemical analyzer designed for cannabis professionals and retail consumers. Under Dreismann's leadership, Roche expanded its portfolio of molecular tests and instruments. Prior to his appointment as CEO of Roche Molecular, Dreismann held other senior positions within Roche, including as head of global business development for Roche Diagnostics, European business unit manager for PCR, head of its business unit for microbiology, R&D positions in microbiology and infectious diseases, and head of manufacturing for infectious disease diagnostics.

Apr 24, 2018

Kenneth Berlin

Former Rosetta Genomics CEO Kenneth Berlin has been appointed president and CEO of Advaxis, effective April 23. Berlin had been president and CEO of Rosetta since 2009 before he stepped down on April 18. That firm and Genoptix have been trying to reach a deal for Genoptix's purchase of the company. Berlin previously has held executive positions at Johnson & Johnson, and J&J firms Veridex and Ortho-Clinical Diagnostics. 

Apr 23, 2018

Brad Kreger

Brad Kreger has been named senior VP of global operations at Fluidigm. Prior to joining the company, he served as senior director of manufacturing operations in Thermo Fisher Scientific's clinical next-generation sequencing division. Before that, he worked for Affymetrix for two decades, most recently as VP of reagent manufacturing and global process engineering.

Apr 20, 2018

Margo Georgiadis

Ancestry announced today that it has appointed Margo Georgiadis as CEO and member of its board of directors. Georgiadis will join the company on May 10. She will succeed Howard Hochhauser, who served as interim CEO since Oct 2017. Hochhauser will return to his position as Ancestry's CFO and COO. Georgiadis previously served as CEO at Mattel, and prior to that as President, Americas at Google.

Apr 20, 2018

William Bonello

NeoGenomics has appointed William Bonello VP of strategy, corporate development and investor relations. Bonello has served as the company's VP, treasurer, and director of corporate development since April of last year. Previously Bonello worked as a healthcare equity analyst covering diagnostic services and product stocks for Craig-Hallum, and as an equity analyst for Piper Jaffray, Wachovia Securities, and RBC Capital Markets. Bonello was also previously senior VP for investor relations at Laboratory Corporation of America.

Pages

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.